World Trade Factory™

Kimberly-Clark to buy Tylenol owner Kenvue in $48.7 bn deal

Kimberly-Clark to buy Tylenol owner Kenvue in $48.7 bn deal

US consumer goods giant Kimberly-Clark announced Monday a $48.7 billion deal to acquire the major health company Kenvue, whose Tylenol painkiller has faced Trump administration allegations of links to increased autism risks.

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.